The EMS Group, with its companies combined in EMS-CHEMIE HOLDING AG, is globally active in the business areas High Performance Polymers and Specialty Chemicals. In the first half of 2017, net sales increased by 6.5% and net operating income (EBIT) by 5.8% compared to the previous year.
Consolidated net sales in Swiss Francs reached CHF 1,067 million (1,002) which represents a growth of 6.5% compared to previous year. As expected, overall economic development in the main markets China, Europe and NAFTA slowed. EMS was able however, to expand its business with innovative speciality products in all regions and customer markets. Particularly pleasing growth was achieved in Asia.
Net operating income (EBIT) increased to CHF 280 million (265), 5.8% above previous year. The operational cash flow (EBITDA) rose by 5.6% to reach CHF 307 million (291). The EBIT margin reached 26.2% (26.4%), the EBITDA margin 28.7% (29.0%). New business with specialty products had a positive effect on result development. Continuing supply shortages are causing raw material prices to increase strongly, making customer sales price increases unavoidable.